Lichen Planopilaris Treatment

Lichen planopilaris treatment aims to suppress inflammation affecting hair follicles and limit further scarring hair loss. Often shortened to LPP, it is a form of cicatricial alopecia. The priority is to identify active disease early and protect remaining follicles. Hair lost where follicles have been destroyed by scarring cannot reliably be restored by a routine hair-growth product.

Lichen Planopilaris Treatment

Lichen planopilaris treatment aims to suppress inflammation affecting hair follicles and limit further scarring hair loss. Often shortened to LPP, it is a form of cicatricial alopecia. The priority is to identify active disease early and protect remaining follicles. Hair lost where follicles have been destroyed by scarring cannot reliably be restored by a routine hair-growth product.

Diagnosis and treatment usually require a dermatologist with experience in scalp disease. This guide explains the assessment, possible prescription routes and practical follow-up. It distinguishes control of inflammation from cosmetic improvement and does not promise that every patch will regrow or that a particular medicine works for everyone.

Recognise a pattern that needs specialist assessment

Explain when thinning or patches began and whether you have scalp burning, tenderness, itching or scale around individual hairs. Some patients notice progression without much discomfort, so absence of itch does not prove that the condition is inactive. Mention eyebrow changes and symptoms involving skin, mouth or nails as these may be relevant to the wider assessment.

Bring older photographs, previous biopsy results and a list of products and treatments used. The clinician needs to distinguish scarring loss from alopecia areata, pattern hair loss, infection and other inflammatory conditions. A smooth patch in a photograph is not enough to confirm LPP, and several types of hair loss can coexist.

Confirm the diagnosis and document a baseline

Examination may include trichoscopy, a close view of the scalp and follicles. A scalp biopsy can be recommended when the findings need confirmation. The clinician selects a useful site, often where activity can be assessed, rather than simply sampling the centre of an old bare patch. Ask what the result would clarify and how it may affect treatment.

Baseline photographs and mapped areas can make later comparison more reliable. Confirm how the service records symptoms, scale, redness and change in hair coverage. A clear baseline matters because everyday lighting and styling can make the scalp look different without representing progression. Ask how and when the biopsy result will be communicated.

Agree treatment goals before comparing prescriptions

Clinical issueMain goalQuestion to clarify
Active follicular inflammationReduce activity and protect remaining folliclesHow response will be assessed
Limited active areasConsider suitable local anti-inflammatory treatmentWhich sites and course are intended
Progressive or more extensive diseaseConsider systemic treatment and monitoringExpected benefit and safety checks
Established scarred areasDiscuss realistic appearance optionsWhat cannot be expected to regrow

Discuss local anti-inflammatory treatment

Selected topical corticosteroids or carefully administered injections may be considered for active areas. Strength, formulation and location should be specified. Ask how to apply a scalp preparation through the hair and whether the plan differs near the face. Do not inject, mix or extend treatment independently because an area remains visibly thin.

Local treatments have risks, including skin thinning or changes at treated sites, and need appropriate review. Tell the clinician about previous reactions or difficulty using the preparation. The useful question is whether inflammation is responding with acceptable adverse effects, rather than whether every application immediately changes hair density. A prescription should include a clear follow-up point.

Consider systemic medicines individually

Depending on activity and progression, a specialist may discuss an oral anti-inflammatory or immune-modifying medicine. Options can include hydroxychloroquine and, in selected circumstances, other agents. Treatment evidence is limited and responses vary. A list of possible medicines is not a recommendation to obtain one without a diagnosis or monitoring plan.

Provide your full medical history, medicine list and information about pregnancy plans or breastfeeding. Ask which blood tests, eye checks or other monitoring relate to the selected drug and your circumstances. Off-label use and local availability should be explained where relevant. Do not stop or restart systemic treatment without discussing the reason and a safe plan with the prescriber.

Measure response over an appropriate interval

Some medicines need time before a response can be judged. Agree the intended trial duration and the signs that would justify continuing, changing or stopping it. Reduced symptoms can be useful, but the clinician should also assess the scalp and any documented progression. Neither a single good day nor a single photograph is sufficient to settle the question.

Keep appointments and safety checks even if symptoms improve. Record adverse effects and contact the service according to the medicine's instructions. If tests or appointments are difficult to access, explain that early so the plan remains safe and realistic. A prescription requiring unavailable monitoring should not simply be continued without review.

Keep hair-growth care separate from inflammation control

A growth treatment may sometimes be discussed for surviving follicles or an additional diagnosis such as pattern hair loss. It does not replace treatment directed at active LPP and cannot recreate follicles destroyed by scarring. Ask which part of the problem each proposed product is intended to address before adding it to the routine.

The minoxidil treatment guide explains a separate prescription discussion. PRP, supplements and other marketed growth treatments should not be assumed to control scarring disease. If a product burns or irritates the scalp, report it. More products can create symptoms that make the original inflammatory condition harder to follow.

Use gentle grooming and discuss cosmetic concerns

Avoid painful traction, aggressive scratching and harsh chemical services over actively inflamed areas. Choose comfortable washing and styling without treating ordinary hygiene as the cause of an immune-mediated disorder. Ask about a tolerated cleanser and how to use prescribed products around your normal hair-care schedule. Hair texture and daily needs should shape the practical advice.

Camouflage fibres, a hairpiece or another removable option may help if appropriate and comfortable. These choices do not replace treatment, but appearance concerns deserve attention alongside inflammation. Discuss attachments or adhesives if they pull or irritate the scalp. Feeling distressed by permanent loss is understandable and should not be dismissed simply because the affected area looks small.

Approach restoration procedures cautiously

Hair transplantation is not a routine solution during active scarring alopecia. Any later consideration requires specialist evaluation of stability, recurrence risk, donor suitability and realistic outcomes. There is no fixed waiting period that can guarantee safety for everyone. Do not commit to a transplant package before the inflammatory diagnosis and its activity have been reviewed.

If a procedure is discussed, ask what evidence supports it in your situation and how recurrence would be detected afterwards. A scarred area behaves differently from ordinary pattern hair loss. The hair transplant guide covers general planning, but LPP introduces additional constraints that need an individual specialist decision.

Plan long-term review and costs

LPP can follow an unpredictable course, and reassessment may be needed even after a calmer period. Report new areas, increasing symptoms or visible progression rather than waiting for major density loss. Sudden pain, pus or fever can indicate a separate complication needing earlier advice. Do not assume every later scalp problem is simply the established condition.

Ask for a breakdown of consultation, biopsy, prescriptions, required monitoring and follow-up. Clarify the likely review schedule and whom to contact between visits. A meaningful plan should prioritise disease control and safety over cosmetic promises. At each review, confirm the current activity, the reason for continuing treatment and the next decision point.

Find your starting point

Explore related topics

Explore treatment guides and prepare your questions for a consultation.

Lichen Planopilaris Treatment: FAQs

Answers to common questions about Lichen Planopilaris Treatment.

LPP is an inflammatory condition affecting hair follicles that can cause permanent scarring hair loss.
The aim is to suppress active inflammation and limit further loss while protecting remaining follicles.
Destroyed follicles cannot reliably regrow hair. Treatment should not promise restoration of every scarred patch.
Yes. Symptoms alone do not determine activity, so examination and comparison over time matter.
It can help confirm the type of scarring alopecia and distinguish other conditions when the clinical findings are uncertain.
Selected local corticosteroids or injections and, when appropriate, systemic anti-inflammatory or immune-modifying medicines may be considered.
No. Suitability and monitoring depend on the individual medical history and prescription plan.
No. It may have an adjunctive role for surviving follicles or another diagnosis but does not replace control of LPP activity.
Active scarring disease is not a routine setting for transplantation. Specialist assessment is necessary before considering restoration.
Record new areas, symptoms, medicine use and adverse effects, and attend the agreed examinations and safety monitoring.